Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of a prognostic gene expression profile test for T1 cutaneous melanoma: Will it help or harm patients?

23 Dec 2018

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Cutaneous Melanoma Detection and Management
Share to Melanoma and MAPK Pathways

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 30586612
DOI: 10.1016/j.jaad.2018.11.063

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of a prognostic gene expression profile test for T1 cutaneous melanoma: Will it help or harm patients?PMID 30586612Read ↗

Machine learning modeling and prognostic value analysis of invasion-related genes in cutaneous melanomaSemantic proximity Read ↗

The Role of Gene Expression Profiling in Management of Cutaneous Squamous Cell Cancer: A ReviewSemantic proximity Read ↗

Prognostic Testing in Uveal Melanoma by Transcriptomic Profiling of Fine Needle Biopsy SpecimensSemantic proximity Read ↗

Molecular markers in malignant cutaneous melanoma: gift horse or one-trick pony?Semantic proximity Read ↗

Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanomaSemantic proximity Read ↗

Guidance of Sentinel Lymph Node Biopsy Decisions In Patients With T1–T2 Melanoma Using Gene Expression ProfilingSemantic proximity Read ↗

Use of Gene Expression and Pathway Signatures to Characterize the Complexity of Human MelanomaSemantic proximity Read ↗

Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile testSemantic proximity Read ↗

A nine-gene signature predicting clinical outcome in cutaneous melanomaSemantic proximity Read ↗

Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patientsSemantic proximity Read ↗

Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patientsSemantic proximity Read ↗

Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.